COSMIC-Linked Ras Mutations at the Interface Between H-Ras and PI3KγRBD Frequently Generate Affinity Increases
Elizabeth H. Mead, Kaeden C. Batz, Kuo-Hsien Shih, Ian R FlemingiD, Corey D TesdahliD, Lucas Lizardos, Joy R ArmendariziD, Jonathan P. HannaniD, Ava M. Hickey, Alan Leyk, Annette H. ErbseiD, Joseph J. FalkeiD
Abstract
The three conventional isoforms of the Ras G-protein (H-, K-, N-Ras) function as molecular on-off switches that regulate a wide array of signaling pathways, including the Ras-PI3K-PIP3-PDK1-AKT pathway that is central to innate immunity and normal cell growth, and is dysregulated in many disease states. Activation of the pathway by Ras requires adequate Ras-PI3K binding affinity. Here we focus on the interface of known structure in the H-Ras:PI3K{gamma} co-complex essential to multiple pathways including directed pseudopod growth in leukocyte chemotaxis. At this interface 10 H-Ras residues, all 100% conserved between the H-, K- and N-Ras isomers, contact the Ras binding domain of PI3K{gamma} (PI3K{gamma}RBD). To investigate the degree to which the native H-Ras:PI3K{gamma}RBD interface is optimized by evolution for maximal binding affinity, 8 interfacial Ras mutations selected from the COSMIC database and the literature were introduced at the contact positions. All 8 Ras mutations were observed to alter the H-Ras:PI3K{gamma}RBD binding affinity, with 4 mutations yielding significant affinity increases and 4 yielding significant affinity decreases. These findings indicate that the native H-Ras:PI3K{gamma}RBD interface provides intermediate, rather than maximal, binding affinity. Such intermediate affinity is consistent with the substantial binding plasticity of the conserved H-, N-, K-Ras effector docking surface, which has evolved to bind a diverse array of effectors. Furthermore, the findings provide evidence that COSMIC-linked mutations at the H-Ras:PI3K{gamma}RBD interface frequently generate affinity increases as well as decreases, with potential implications for molecular mechanisms of disease and for tool development in cell biology.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 27th percentile
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The binding landscape of Ras/effector interactions provides insights on Ras switching and oncogenesis
Atilio Tomazini, Sagara Gurusinghe, … Julia M Shifman·bioRxiv·Nov 5, 2026
- K-Ras G-domain binding with signaling lipid phosphoinositides: PIP2 association, orientation, function
Shufen Cao, Stacey Chung, … Matthias Buck·bioRxiv·May 16, 2018
- KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
T. H. Tran, A. H. Chan, … D. K. Simanshu·bioRxiv·Jul 31, 2020
- Crystal structure reveals the full Ras:Raf interface and advances mechanistic understanding of Raf activation
- Structure-based prediction of Ras-effector binding affinities and design of 'branchegetic' interface mutations
Philipp Junk, Christina Kiel·StructurePeer-reviewed·May 10, 2023
- Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS